drugset / Trial / NCT07567742

Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

NCT07567742

Phase 2 Not yet recruiting 130 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelPrevention

Summary

This clinical trial aims to understand whether taurine can prevent and reduce severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing radiotherapy.

Timeline

Start
2026-05-06
Primary completion
2027-03-30
Completion
2029-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Taurine Other / unclassified 1 g Oral